|
1
|
Ministry of Health and Welfare, Republic
of China (Taiwan). https://www.mohw.gov.tw/cp-3425-33347-2.html.
2017
|
|
2
|
Li H, Sun K, Zhao R, Hu J, Hao Z, Wang F,
Lu Y, Liu F and Zhang Y: Inflammatory biomarkers of coronary heart
disease. Front Biosci (Schol Ed). 10:185–196. 2018. View Article : Google Scholar
|
|
3
|
Antonopoulos AS, Papanikolaou E, Vogiatzi
G, Oikonomou E and Tousoulis D: Anti-inflammatory agents in
peripheral arterial disease. Curr Opin Pharmacol. 39:1–8. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Salvo F, Bezin J, Bosco-Levy P, Letinier
L, Blin P, Pariente A and Moore N: Pharmacological treatments of
cardiovascular diseases: Evidence from real-life studies. Pharmacol
Res. 118:43–52. 2017. View Article : Google Scholar
|
|
5
|
Brown AC: An overview of herb and dietary
supplement efficacy, safety and government regulations in the
United States with suggested improvements. Part 1 of 5 series. Food
Chem Toxicol. 107:449–471. 2017. View Article : Google Scholar
|
|
6
|
Aggarwal M, Aggarwal B and Rao J:
Integrative medicine for cardiovascular disease and prevention. Med
Clin North Am. 101:895–923. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shukla Y and Singh M: Cancer preventive
properties of ginger: a brief review. Food Chem Toxicol.
45:683–690. 2007. View Article : Google Scholar
|
|
8
|
Baliga MS, Haniadka R, Pereira MM,
Thilakchand KR, Rao S and Arora R: Radioprotective effects of
Zingiber officinale Roscoe (ginger): past, present and future. Food
Funct. 3:714–723. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Borrelli F, Capasso R, Aviello G, Pittler
MH and Izzo AA: Effectiveness and safety of ginger in the treatment
of pregnancy-induced nausea and vomiting. Obstet Gynecol.
105:849–856. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ghayur MN, Gilani AH, Afridi MB and
Houghton PJ: Cardio-vascular effects of ginger aqueous extract and
its phenolic constituents are mediated through multiple pathways.
Vascul Pharmacol. 43:234–241. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Connell DW and McLachla R: Natural pungent
compounds: IV. Examination of the gingerols, shogaols, paradols and
related compounds by thin-layer and gas chromatography. J
Chromatogr A. 67:29–35. 1972. View Article : Google Scholar
|
|
12
|
Jolad SD, Lantz RC, Chen GJ, Bates RB and
Timmermann BN: Commercially processed dry ginger (Zingiber
officinale): composition and effects on LPS-stimulated
PGE2 production. Phytochemistry. 66:1614–1635. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Macleod AJ and Pieris NM: Volatile aroma
constituents of Sri Lankan ginger. Phytochemistry. 23:353–359.
1984. View Article : Google Scholar
|
|
14
|
Dugasani S, Pichika MR, Nadarajah VD,
Balijepalli MK, Tandra S and Korlakunta JN: Comparative antioxidant
and anti-inflammatory effects of [6]-gingerol, [8]-gingerol,
[10]-gingerol and [6]-shogaol. J Ethnopharmacol. 127:515–520. 2010.
View Article : Google Scholar
|
|
15
|
Mashhadi NS, Ghiasvand R, Askari G, Hariri
M, Darvishi L and Mofid MR: Anti-oxidative and anti-inflammatory
effects of ginger in health and physical activity: review of
current evidence. Int J Prev Med. 4(Suppl 1): S36–S42.
2013.PubMed/NCBI
|
|
16
|
Weng CJ, Chou CP, Ho CT and Yen GC:
Molecular mechanism inhibiting human hepatocarcinoma cell invasion
by 6-shogaol and 6-gingerol. Mol Nutr Food Res. 56:1304–1314. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shao Y, Yu Y, Li C, Yu J, Zong RR and Pei
CG: Synergistic effect of quercetin and 6-gingerol treatment in
streptozotocin induced type 2 diabetic rats and poloxamer P-407
induced hyperlipidemia. Rsc Adv. 6:12235–12242. 2016. View Article : Google Scholar
|
|
18
|
Ok S and Jeong WS: Optimization of
extraction conditions for the 6-shogaol-rich extract from ginger
(Zingiber officinale Roscoe). Prev Nutr Food Sci. 17:166–171. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chang LC and Yu YL: Dietary components as
epigenetic-regulating agents against cancer. Biomedicine (Taipei).
6:22016. View Article : Google Scholar
|
|
20
|
Gilani AH, Mandukhail SU, Iqbal J,
Yasinzai M, Aziz N, Khan A and Najeeb-ur-Rehman: Antispasmodic and
vasodilator activities of Morinda citrifolia root extract are
mediated through blockade of voltage dependent calcium channels.
BMC Complement Altern Med. 10:22010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sakanashi M, Matsuzaki T and Aniya Y:
Nitroglycerin relaxes coronary artery of the pig with no change in
glutathione content or glutathione S-transferase activity. Br J
Pharmacol. 103:1905–1908. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun B, Wang W and Salvaterra PM:
Functional analysis and tissue-specific expression of Drosophila
Na+, K+-ATPase subunits. J Neurochem.
71:142–151. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cohen RA, Plane F, Najibi S, Huk I,
Malinski T and Garland CJ: Nitric oxide is the mediator of both
endothelium-dependent relaxation and hyperpolarization of the
rabbit carotid artery. Proc Natl Acad Sci USA. 94:4193–4198. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu CC, Yang SH, Hsia SM, Wu CH and Yen GC:
Inhibitory effects of Phyllanthus emblica L. on hepatic steatosis
and liver fibrosis in vitro. J Funct Foods. 20:20–30. 2016.
View Article : Google Scholar
|
|
25
|
Lee CF, Yang JS, Tsai FJ, Chiang NN, Lu
CC, Huang YS, Chen C and Chen FA: Kaempferol induces
ATM/p53-mediated death receptor and mitochondrial apoptosis in
human umbilical vein endothelial cells. Int J Oncol. 48:2007–2014.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Randriamboavonjy V, Busse R and Fleming I:
20-HETE-induced contraction of small coronary arteries depends on
the activation of Rho-kinase. Hypertension. 41:801–806. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Randriamboavonjy V, Kiss L, Falck JR,
Busse R and Fleming I: The synthesis of 20-HETE in small porcine
coronary arteries antagonizes EDHF-mediated relaxation. Cardiovasc
Res. 65:487–494. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tomiyama H and Yamashina A: Beta-blockers
in the management of hypertension and/or chronic kidney disease.
Int J Hypertens. 2014:9192562014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gupta S and Wright HM: Nebivolol: a highly
selective beta1-adrenergic receptor blocker that causes
vasodilation by increasing nitric oxide. Cardiovasc Ther.
26:189–202. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Flagg TP, Enkvetchakul D, Koster JC and
Nichols CG: Muscle KATP channels: recent insights to
energy sensing and myoprotection. Physiol Rev. 90:799–829. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Quast U, Stephan D, Bieger S and Russ U:
The impact of ATP-sensitive K+ channel subtype
selectivity of insulin secretagogues for the coronary vasculature
and the myocardium. Diabetes. 53(Suppl 3): S156–S164. 2004.
View Article : Google Scholar
|
|
32
|
Drain P, Li L and Wang J: KATP
channel inhibition by ATP requires distinct functional domains of
the cytoplasmic C terminus of the pore-forming subunit. Proc Natl
Acad Sci USA. 95:13953–13958. 1998. View Article : Google Scholar
|
|
33
|
Valavanidis A, Vlahogianni T, Dassenakis M
and Scoullos M: Molecular biomarkers of oxidative stress in aquatic
organisms in relation to toxic environmental pollutants. Ecotoxicol
Environ Saf. 64:178–189. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang F, Zhao S, Li F, Zhang B, Qu Y, Sun
T, Luo T and Li D: Investigation of antioxidant interactions
between Radix Astragali and Cimicifuga foetida and identification
of synergistic antioxidant compounds. PLoS One. 9:e872212014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Padma VV: An overview of targeted cancer
therapy. Biomedicine (Taipei). 5:192015. View Article : Google Scholar
|
|
36
|
Tesfamariam B and Halpern W:
Endothelium-dependent and endothelium-independent vasodilation in
resistance arteries from hypertensive rats. Hypertension.
11:440–444. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nabel EG, Ganz P, Gordon JB, Alexander RW
and Selwyn AP: Dilation of normal and constriction of
atherosclerotic coronary arteries caused by the cold pressor test.
Circulation. 77:43–52. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jiang J, Zheng JP, Li Y, Gan Z, Jiang Y,
Huang D, Li H, Liu Z and Ke Y: Differential contribution of
endothelium-derived relaxing factors to vascular reactivity in
conduit and resistance arteries from normotensive and hypertensive
rats. Clin Exp Hypertens. 38:393–398. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ghalayini IF: Nitric oxide-cyclic GMP
pathway with some emphasis on cavernosal contractility. Int J Impot
Res. 16:459–469. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pratt PF, Rosolowsky M and Campbell WB:
Mediators of arachidonic acid-induced relaxation of bovine coronary
artery. Hypertension. 28:76–82. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu J, Seibold SA, Rieke CJ, Song I,
Cukier RI and Smith WL: Prostaglandin endoperoxide H synthases:
peroxidase hydro-peroxide specificity and cyclooxygenase
activation. J Biol Chem. 282:18233–18244. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Steed MM and Tyagi SC: Mechanisms of
cardiovascular remodeling in hyperhomocysteinemia. Antioxid Redox
Signal. 15:1927–1943. 2011. View Article : Google Scholar :
|
|
43
|
Ilkhanizadeh B, Shirpoor A, Khadem Ansari
MH, Nemati S and Rasmi Y: Protective Effects of ginger (Zingiber
officinale) extract against diabetes-induced heart abnormality in
rats. Diabetes Metab J. 40:46–53. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mittal M, Siddiqui MR, Tran K, Reddy SP
and Malik AB: Reactive oxygen species in inflammation and tissue
injury. Antioxid Redox Signal. 20:1126–1167. 2014. View Article : Google Scholar :
|
|
45
|
Förstermann U and Li H: Therapeutic effect
of enhancing endothelial nitric oxide synthase (eNOS) expression
and preventing eNOS uncoupling. Br J Pharmacol. 164:213–223. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Matsumoto T, Goulopoulou S, Taguchi K,
Tostes RC and Kobayashi T: Constrictor prostanoids and uridine
adenosine tetraphosphate: vascular mediators and therapeutic
targets in hypertension and diabetes. Br J Pharmacol.
172:3980–4001. 2015. View Article : Google Scholar : PubMed/NCBI
|
